Search Results - "Manzo, Julia"

Clinical trial cytology: Use of on‐site evaluation of small biopsy and FNA samples for clinical trials and biomarker research studies by Manzo, Julia L., Cuda, Jackie, Pantanowitz, Liron, Xing, Juan, Yu, Jing, Beasley, H. Scott, Dhir, Rajiv, Monaco, Sara E.

“…BACKGROUND After increased requests for biopsies for clinical trials and biomarker research, the University of Pittsburgh Medical Center created a clinical…”
Get full text

Clinical Trial Cytology: On-site Evaluation to Facilitate Samples for Clinical Trials and Biomarker Research by Monaco, Sara, MD, Cuda, Jacqueline, CT(ASCP), Xing, Juan, MD, Dhir, Rajiv, MD, MBA, Manzo, Julia, BS, Pantanowitz, Liron, MD

Get full text

Yield of adequate tissue on research biopsies with pathologic review by Eden, Elizabeth, Pahuja, Shalu, Manzo, Julia, Yu, Jing, Puhalla, Shannon

“…Abstract only…”
Get full text

A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer by Manzo, Julia, Puhalla, Shannon, Pahuja, Shalu, Ding, Fei, Lin, Yan, Appleman, Leonard, Tawbi, Hussein, Stoller, Ronald, Lee, James J., Diergaarde, Brenda, Kiesel, Brian F., Yu, Jing, Tan, Antoinette R., Belani, Chandra P., Chew, Helen, Garcia, Agustin A., Morgan, Robert J., Wahner Hendrickson, Andrea E., Visscher, Daniel W., Hurley, Rachel M., Kaufmann, Scott H., Swisher, Elizabeth M., Oesterreich, Steffi, Katz, Tiffany, Ji, Jiuping, Zhang, Yiping, Parchment, Ralph E., Chen, Alice, Duan, Wenrui, Giranda, Vincent, Shepherd, Stacie P., Ivy, S. Percy, Chu, Edward, Beumer, Jan H.

“…Purpose BRCA1 or BRCA2 mutated cancers ( BRCA mut) have intrinsic sensitivity to PARP inhibitors due to deficiency in homologous recombination-mediated DNA…”
Get full text

Community-Based Hospitals Benefit From Restrictive Transfusion Practices by Hill, James L., Dawson, Jennifer L., Ramic, Meghan, Manzo, Julia, Pronovost, Peter J.

“…Blood availability was uncertain during the COVID-19 pandemic, yet transfusion remained a common and sometimes necessary procedure. Substantial work on…”
Get full text